Ryoichi Nagata

Directeur Général chez SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.

Profil

Dr. Ryoichi Nagata is a President & Representative Director at PPD-SNBL KK, a Chairman at SNBL Clinical Pharmacology Center, Inc., a Chairman at Saifuku Gakuen, a Chairman at Ruika Therapeutics, Inc., a Chairman at Medipolis Medical Research Institute, a Chief Executive Officer at Translational Research USA, Inc., a Chairman at Pharmaron CPC, Inc., a Chairman at RKE Co., Ltd., a Chairman at SNBL USA Ltd., a Chief Executive Officer at SNBL Europe, Ltd. and a Chairman, Chief Executive & Health Officer at Shin Nippon Biomedical Laboratories, Ltd. He is on the Board of Directors at PPD-SNBL KK and Shin Nippon Biomedical Laboratories (Cambodia) Ltd. Dr. Nagata was previously employed as a President, Chief Executive Officer & Director by Satsuma Pharmaceuticals, Inc. and a Chairman by SNBL China, Ltd. He also served on the board at Shin Nippon Biomedical Laboratories India Pvt Ltd.

Postes actifs de Ryoichi Nagata

Sociétés	Poste	Début
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.	Directeur Général	01/04/2014
SNBL USA Ltd.	Président	01/12/2009
Medipolis Medical Research Institute	Président	01/03/2006
SNBL Clinical Pharmacology Center, Inc.	Président	01/06/2012
SNBL Europe, Ltd.	Directeur Général	01/07/1991
RKE Co., Ltd.	Président	01/04/2003
Pharmaron CPC, Inc.	Président	01/10/2004
Translational Research USA, Inc.	Directeur Général	01/11/2004
Shin Nippon Biomedical Laboratories (Cambodia) Ltd.	Directeur/Membre du Conseil	01/01/2005
░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░	░░░░░░░░░░

Anciens postes connus de Ryoichi Nagata

Sociétés	Poste	Fin
░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░ ░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	-
░░░░ ░░░░░░ ░░░░	░░░░░░░░░░	-